Frontage Laboratories Completes Acquisition of Teddy Clinical Research Laboratory (Shanghai)
March 4, 2026
Frontage Laboratories, Inc. completed its acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. to expand Frontage’s global central laboratory capabilities and strengthen its footprint in China and the Asia-Pacific region. Teddy Lab will be integrated into Frontage’s “one-stop shop” CRO/CDMO service platform to support growing demand for domestic and multi-regional clinical trials.
- Buyers
- Frontage Laboratories, Inc., Frontage Laboratories (wholly owned subsidiary of Frontage Holdings Corporation)
- Targets
- Teddy Clinical Research Laboratory (Shanghai), Ltd.
- Industry
- Healthcare Services
- Location
- China
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Wedgewood Pharmacy Acquires Front Range Laboratories
February 23, 2023
Healthcare Services
Wedgewood Pharmacy acquired Front Range Laboratories (FRL), a Loveland, Colorado-based testing laboratory that provides analytical and microbiological testing to compounding pharmacies. The acquisition, which closed on February 23 (terms undisclosed), brings in FRL's founders Michael and Jennifer Travis to remain with the business and allows Wedgewood to shorten testing turnaround times, better control costs, and increase testing capacity to support growing demand in animal health.
-
PharmaLegacy Laboratories Acquires San Diego-Based BTS Research
September 16, 2024
Healthcare Services
PharmaLegacy Laboratories has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO), expanding PharmaLegacy's in vitro and in vivo pharmacology and GLP toxicology capabilities. The acquisition gives PharmaLegacy a local presence in San Diego to increase study capacity and support clients across the United States and North America.
-
Adare Pharma Solutions Acquires Frontida BioPharm
December 1, 2021
Pharmaceuticals
Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.
-
AccelLAB Management Acquires AccelLAB from Charles River Laboratories
January 18, 2024
Medical Devices
Key members of AccelLAB's management team acquired AccelLAB from Charles River Laboratories, and the business will operate independently as a standalone preclinical CRO serving the medical device and biologics markets. Fairmount Partners served as exclusive financial advisor to Charles River in the divestiture; AccelLAB employs approximately 100 staff across facilities in Boisbriand and Terrebonne, Quebec, Canada.
-
Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint
June 3, 2024
Pharmaceuticals
Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.
-
Headlands Research Acquires Clinical Research Professionals (St. Louis)
October 12, 2023
Healthcare Services
Headlands Research has acquired Clinical Research Professionals, a St. Louis–area clinical research site, expanding Headlands' network and geographic reach. The acquisition adds experienced investigators and capabilities across therapeutic areas including gastroenterology, neurology, and vaccines, supporting increased participant recruitment and trial capacity.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.